| Document |
Document Title |
|
WO/2008/083064A1 |
The present invention provides a process for decomposing a cumene hydroperoxide to produce phenol and acetone including: (1) introducing a process stream (21) containing cumene hydroperoxide into a reaction vessel (40); (2) introducing i...
|
|
WO/2008/065367A1 |
A process for preparing catechol derivatives comprising the steps of: i) admixing an aromatic compound with a dioxygenase enzyme to provide an intermediate cis-dihydrodiol aromatic compound; ii) separating the cis-dihydrodiol aromatic co...
|
|
WO/2008/065939A1 |
Disclosed is an adamantane derivative having adequate optical characteristics such as transparency and (long-term) light resistance, adequate electrical characteristics such as long-term heat resistance and dielectric constant, and good ...
|
|
WO/2008/062644A1 |
Disclosed is a commercially practical method for obtaining a corresponding alkylated aromatic compound by a single reaction step wherein a ketone and an aromatic compound are directly reacted with each other. Specifically disclosed is a ...
|
|
WO/2008/053974A1 |
Disclosed is a radiation-sensitive composition containing a resist compound which enables to obtain a resist pattern with a good shape, while having high sensitivity, high resolution, high etching resistance and low outgas. Also disclose...
|
|
WO/2008/043567A1 |
The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provid...
|
|
WO/2008/038801A1 |
A method of synthesizing a diol or a polydiol by reductively coupling carbonyl compounds in a solvent with the use of 12CaO.7Al2O3 having 1019 cm-3 or more but not more than 2.3x1021 cm-3 electrons per cage as a reducing agent. A method ...
|
|
WO/2008/029018A1 |
The present invention relates to a process for preparing highly pure hydroquinone freed of the impurities resulting from its preparation process. The process of the invention is characterized in that it comprises at least the following s...
|
|
WO/2008/030771A1 |
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
|
|
WO/2008/023438A1 |
A process for producing 2-fluoro-6-halophenols as intermediates; a process for producing 2-alkoxy-3-fluorophenols, and further 1,2-dialkoxy-3-fluorobenzenes, from the 2-fluoro-6-halophenols; a second process for producing 1,2-dialkoxy-3-...
|
|
WO/2008/016496A2 |
A process for producing a stable polymer such as poly(hydroxystyrene) which comprises the decarboxylation of a corresponding phenolic in the presence of a non-amine basic catalyst and a polar organic solvent, followed by the polymerizati...
|
|
WO/2008/012321A1 |
A subject-matter of the present invention is a novel process for the synthesis of (E)- stilbene derivatives targeted at obtaining in particular resveratrol and piceatannol.
|
|
WO/2008/012108A2 |
The invention relates to a process for the preparation of polyhydroxylated stilbenes starting from a compound of the formula (I) formula (VI) or formula (IX).
|
|
WO/2008/009675A2 |
The invention relates to antioxidants, mixtures, preparations, dyes, vesicles, carotinoid formulations, dermocosmetic products, pharmaceuticals, food and fodder, and other solids or liquids or the mixtures thereof, which contain 3,3'-dih...
|
|
WO/2008/010526A1 |
This invention provides 1,1-bis(4-hydroxyphenyl)-1-phenylethane which is in a crystal form characterized by an X-ray diffraction pattern having a sharp and strong peak at 16.4°, three sharp and medium intensity peaks respectively at 13Â...
|
|
WO/2008/011266A1 |
A new ionic compound is provided that is derived from N.N-dimethylaniline and pentafluorphenol in amounts such that there are at least 2 equivalents of pentafluorophenol per equivalent of the N.N-dimethylaniline.
|
|
WO/2008/008498A2 |
Trisubstituted phenol compounds and methods of using the compounds, e.g., for anesthetizing a subject, are disclosed.
|
|
WO/2008/006276A1 |
A type of novel compounds having the symmetric structure of formula I, which can inhibit the congregation and fibrosis of β-amyloid protein, their pharmaceutically accepted salts, and preparation methods thereof. The pharmaceutical comp...
|
|
WO/2008/008492A2 |
Substituted hydrofluoroalkylphenol compounds and methods of using the compounds, e.g., for anesthetizing a subject, are disclosed.
|
|
WO/2008/003737A1 |
The invention relates to a novel method for producing 3,3'-dihydroxyisorenieratine of formula (I), and to novel intermediate products obtained according to said method.
|
|
WO/2008/003742A1 |
The invention relates to an improved method for producing 3,3'-dihydroxyisorenieratine of formula (I), and to novel intermediate products obtained according to said method.
|
|
WO/2008/003460A1 |
The invention relates to a novel process for the preparation of asenapine, i.e. trans-5- chloro-2-methyl-2,3,3a, 12b-tetrahydro-1 H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, as well as to novel intermediate products for use in said process.
|
|
WO/2008/000955A1 |
The invention relates to a method for preparing purified hydroquinone and forming same. The invention is intended to be used to obtain a purified hydroquinone from raw compounds essentially containing hydroquinone associated with very sm...
|
|
WO/2008/000956A1 |
The present invention relates to a new form of hydroquinone in flake form, and to the process for obtaining it. The process of the invention for preparing hydroquinone flakes is characterized in that it comprises the following steps: - i...
|
|
WO/2008/000954A2 |
The present invention relates to a process of separation and purification allowing purified hydroquinone to be obtained from crude mixtures essentially containing hydroquinone in combination with very small amounts of impurities includin...
|
|
WO/2008/000957A2 |
The present invention relates to a process for preparing hydroquinone devoid of the impurities resulting from its preparation process. The process for preparing purified hydroquinone from a crude hydroquinone essentially containing hydro...
|
|
WO/2007/147251A1 |
The present invention provides the use of pelorol analogs of Formula, ( I ) and pharmaceutical compositions thereof as modulators of SHIP 1 activity. A compound or a pharmaceutical composition of the present invention may be used for the...
|
|
WO/2007/147897A1 |
The present invention relates to a process for preparing optically active 2-halo-l-phenylethanol derivatives by the catalytic asymmetric transfer hydrogenation of the corresponding ketones, and to optically active conversion products obt...
|
|
WO/2007/140939A1 |
The invention relates to a process for the preparation of a hydroxy-aromatic compound. The process comprises the step of bringing a starting compound according to formula (I) together with an alkanol hemiacetal according to formula (II) ...
|
|
WO/2007/142353A1 |
Disclosed are a novel tris(formylphenol) represented by the general formula shown below and a polynuclear phenol derived from the tris(formylphenol), each of which is useful as a raw material for a heat-resistant material, a raw material...
|
|
WO/2007/137020A2 |
A method for decomposing di(phenylalkyl)peroxides to hydroxybenzenes and phenylalkene(s) using solid catalyst.
|
|
WO/2007/132575A1 |
A process for producing bisphenol A which comprises: (A) a condensation reaction step in which phenol is condensed with acetone in the presence of an acid catalyst; (B) a concentration step in which the reaction mixture is concentrated; ...
|
|
WO/2007/126483A1 |
A process comprising the steps of dissolving a dihydric phenol in a solvent to form a solution A, contacting the solution A with an adsorbent material selected from the group consisting of metal oxides, modified metal oxides, activated c...
|
|
WO/2007/126542A2 |
A process comprising the steps of dissolving a dihydric phenol in a solvent to form a solution A; contacting the solution A with a zeolite; filtering the zeolite to form a solution B; adding an anti-solvent to the solution B to form a so...
|
|
WO/2007/118601A1 |
The present invention relates to method for producing phenol comprising: a) oxidizing cumene to form an oxidation product containing cumene hydroperoxide; b) cleaving said oxidation product using an acidic catalyst to form a cleavage pro...
|
|
WO/2007/118600A1 |
The present invention relates to a continuous method for treating a crude phenol stream comprising methylbenzofuran and hydroxyacetone by passing the crude phenol stream through at least two reactors connected in series the reactors cont...
|
|
WO/2007/118329A1 |
The present invention relates to the treatment of tuberculosis (mycobacterial infections) by the use of KshAB complex inhibitors, or a KstD molecule, or a HsaAB complex, or a HsaC molecule, or a HsaD molecule. The application also includ...
|
|
WO/2007/116967A1 |
Disclosed is a novel bisphenol compound represented by the following formula (1). (In the formula (1), R represents an alkyl group having 1-6 carbon atoms, an aryl group having 6-12 carbon atoms, a nitro group, an amino group or a haloge...
|
|
WO/2007/110883A1 |
The present invention relates to a single step, microwave induced process for the preparation of substituted stilbenes and its analogs. Particularly, provides a method for the preparation of commercially important 2- or 4-hydroxy substit...
|
|
WO/2007/112296A2 |
A method for reducing contaminants during synthesis of pentachlorophenol includes providing a phenol-based starting material and a catalyst, which form a reaction mixture. A chlorine flow is introduced so that it is in contact with the r...
|
|
WO/2007/110881A1 |
The invention entitled "A Microwave Induced One Pot Process for The Preparation of Arylethenes" provides a method for the preparation of commercially important 2- or 4-hydroxy substituted arylethenes like styrenes or stilbenes in one pot...
|
|
WO/2007/109804A2 |
The present invention relates to extracts of cinnamon species plant material prepared by supercritical CO2 extractions methods.
|
|
WO/2007/108259A1 |
A process for producing bisphenol A with the use of a horizontal belt filter, the horizontal belt filter used for solid-liquid separation of slurry formed by crystallization of bisphenol A/phenol adduct from a phenol solution of bispheno...
|
|
WO/2007/104242A1 |
The invention has disclosed 1,2,3-trihydroxy benzene and its derivatives or pharmaceutically acceptable salts of formula I for zinc ion metal-protease inhibition. These compounds are used for selective depressants of zinc ion metal-prote...
|
|
WO/2007/103478A2 |
Tyrosine was converted to p-hydroxystyrene in a two-step reaction without purification of individual intermediates. Conditions were determined for bromination of tyrosine in which reactive intermediates were formed. The mixture of these ...
|
|
WO/2007/102594A1 |
A polymer complex which has two or more kinds of pores capable of selectively taking up and/or releasing and/or transporting specific compounds ranging from gaseous low molecules to high molecules such as proteins and other living-body-d...
|
|
WO/2007/099162A2 |
The present invention relates to a compound of general formula (I) below in which R1, R2 and R3 represent, independently of one another, a hydrogen atom or a C1-C6 alkyl group or a (C1-C6 alkyl)carbonyl group, R4, R5, R6 and R7 represent...
|
|
WO/2007/094124A1 |
A liquid containing one or more bis(hydroxyphenyl)propane compounds is brought into contact with a strongly acid cation-exchange resin to isomerize any bis(hydroxyphenyl)propane compound other than bisphenol A [2,2-bis(4-hydoxyphenyl)pro...
|
|
WO/2007/095462A2 |
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are di...
|
|
WO/2007/093358A1 |
A process for producing phenol and methyl ethyl ketone comprises contacting benzene and a C4 alkylating agent under alkylation conditions and in the presence of an alkylation catalyst comprising at least one molecular sieve of the MCM-22...
|
